New study: pharma deal savings overstated by government
Economist Paul Gorecki has found that the state’s deal with major medicine suppliers will generate just €290m in real savings
The government has overstated the real savings that its medicines deal with pharmaceutical companies will yield by €310 million, according to a Trinity College and ESRI economist.
Paul Gorecki has published a study which shows that the state’s deal with major medicine suppliers will generate just €290 million in real savings.
Minister for Health Simon Harris had claimed the deal with the Irish Pharmaceutical Healthcare Association (IPHA) would deliver savings of €600 million.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Senator calls for Oireachtas committee on autism ‘as a matter of urgency’
Micheál Carrigy said a dedicated committee was needed for those with ‘lived experience’ to feed into a forthcoming government report on autism
British health expert returns to help cut hospital waiting lists
Martin Connor, a policy advisor to the previous coalition, and his new company aim to improve delivery of data management systems to the HSE
Almost half of 18-34 year olds plan to change job in the next year
New research shows mental health of young workers has been negatively impacted by the pandemic